Page last updated: 2024-10-30

lansoprazole and Erythema Multiforme

lansoprazole has been researched along with Erythema Multiforme in 2 studies

Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.

Erythema Multiforme: A skin and mucous membrane disease characterized by an eruption of macules, papules, nodules, vesicles, and/or bullae with characteristic bull's-eye lesions usually occurring on the dorsal aspect of the hands and forearms.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Kikuchi, S1
Nobeyama, Y1
Saeki, H1
Asahina, A1
Heaton, NR1
Edmonds, EV1
Francis, ND1
Bunker, CB1
Bowling, JC1
Morar, N1

Other Studies

2 other studies available for lansoprazole and Erythema Multiforme

ArticleYear
Characteristics of cutaneous adverse drug reactions caused by triple-combination drug therapy used for Helicobacter pylori eradication.
    The Journal of dermatology, 2020, Volume: 47, Issue:3

    Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithrom

2020
Fatal toxic epidermal necrolysis due to lansoprazole.
    Clinical and experimental dermatology, 2004, Volume: 29, Issue:6

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Drug Eruptions; Erythema Multiform

2004